Kyntra Bio, Inc.
KYNB
$7.94
-$0.10-1.22%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 91.32M | 87.24M | 88.98M | 117.98M | 23.37M |
| Total Receivables | 347.00K | 9.04M | 4.22M | 10.12M | 136.00K |
| Inventory | 3.38M | 3.38M | 3.74M | 3.86M | 3.86M |
| Prepaid Expenses | 943.00K | 1.14M | 1.02M | 768.00K | 1.03M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 833.00K | 556.00K | 1.12M | 695.00K | 133.93M |
| Total Current Assets | 96.83M | 101.36M | 99.07M | 133.42M | 162.32M |
|
|
|||||
| Total Current Assets | 96.83M | 101.36M | 99.07M | 133.42M | 162.32M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 241.00K | 248.00K | 361.00K | 556.00K | 15.73M |
| Total Assets | 101.08M | 109.63M | 119.59M | 137.01M | 178.06M |
|
|
|||||
| Total Accounts Payable | 7.51M | 5.09M | 3.75M | 5.09M | 10.48M |
| Total Accrued Expenses | 15.57M | 8.61M | 9.51M | 8.90M | 17.19M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | 73.73M |
| Total Finance Division Other Current Liabilities | 12.96M | 14.42M | 15.98M | 21.98M | 54.49M |
| Total Other Current Liabilities | 12.96M | 14.42M | 15.98M | 21.98M | 54.49M |
| Total Current Liabilities | 36.04M | 28.11M | 29.24M | 35.97M | 155.90M |
|
|
|||||
| Total Current Liabilities | 36.04M | 28.11M | 29.24M | 35.97M | 155.90M |
| Long-Term Debt | -- | 19.25M | 19.56M | 19.47M | 19.40M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 73.18M | 71.56M | 66.32M | 64.09M | 183.79M |
| Total Liabilities | 109.22M | 118.92M | 115.12M | 119.53M | 359.09M |
|
|
|||||
| Common Stock & APIC | 1.68B | 1.68B | 1.68B | 1.68B | 1.67B |
| Retained Earnings | -1.71B | -1.72B | -1.71B | -1.69B | -1.89B |
| Treasury Stock & Other | -1.19M | -1.89M | -2.18M | -2.21M | -4.79M |
| Total Common Equity | -30.14M | -43.80M | -30.04M | -17.03M | -223.00M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -30.14M | -43.80M | -30.04M | -17.03M | -223.00M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 22.00M | 34.51M | 34.51M | 34.51M | 41.97M |
| Total Equity | -8.14M | -9.29M | 4.48M | 17.49M | -181.03M |
|
|
|||||